Hypermethylation of the CYP24A1 promoter region, with associated epigenetic silencing of CYP24A1 expression, has been identified in prostate cancer cell line PC3 [104] and tumor-derived endothelial cells (TDEC) [105]. The gene discussed is CYP24A1; the disease is neoplasm.